RxDoctor Payments DataLook up a doctor →

Bradley Miller

Pediatric Endocrinology · Minneapolis, MNNPI 1184633059

Payments from drug & device makers

$1,326,650in general payments, 2019–2025

Across 803 payments — averaging $1652.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$282K
  • Novo Nordisk AS$233K
  • AbbVie$155K
  • Novo Nordisk Health Care AG$151K
  • Ascendis Pharma Endocrinology Inc$97K
  • Biomarin Pharmaceutical Inc.$95K
  • plus $313K from 20 others
$23,790in research payments, 2019–2025

Across 13 payments — averaging $1830.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$24K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,326,650 in reported general payments places this provider in the 95th percentile of 25 pediatric endocrinology providers in Minnesota.

See all pediatric endocrinology providers in Minnesota

Other pediatric endocrinology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →